Examining the Potential Role of Opioid Settlement Funds in the Face of Impending Federal Budget Reductions for Substance Use Disorders
研究了阿片类药物和解基金能否替代或补充联邦物质使用障碍资金，发现各州人均和解基金与联邦资金差距较大，仅俄勒冈州和解基金超过联邦资金，表明和解基金无法替代联邦资金。
OBJECTIVE: To assess the potential of opioid settlement dollars disbursed to state and local governments to replace or supplement federal substance use disorder (SUD) funding. STUDY SETTING AND DESIGN: For each state, we calculated the percentage of Substance Use and Mental Health Services Administration (SAMHSA) SUD funding for each state that can be offset by settlement funds. DATA SOURCES AND ANALYTIC SAMPLE: We estimated annual opioid settlement distributions (2022-2038) from KFF Health News and SAMHSA-funded SUD awards (2024) from SAMHSA's website and the Tracking Accountability in Government Grants System. PRINCIPAL FINDINGS: Across states, the mean difference between SAMHSA SUD funds and settlement funds was $56.83 (SD: $53.76) per capita, and the mean percentage of SAMHSA SUD funding that could be replaced by settlement funds was 51.16 (SD: 28.46) per capita. Oregon was the only state where settlement disbursements exceeded SAMHSA SUD funding. CONCLUSIONS: Substantial gaps remain between current federal SUD funding and what opioid settlement funds can offset. Our findings underscore that opioid settlement funds are not a viable replacement for federal funding, both because they were never intended to serve this purpose, and because they are insufficient in scale.